Clinical trial
A Randomized, Controlled, Open-label, Multi-center Study to Evaluate the Effect and Benefit of Diabetes Management Decision Support Software for Blood Glucose Control
NCT02934893 is registered in ClinicalTrials.gov with Rimidi Diabetes, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled, Open-label, Multi-center Study to Evaluate the Effect and Benefit of Diabetes Management Decision Support Software for Blood Glucose Control
- Lead sponsor
- Rimidi Diabetes, Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 30, 2015
- Completion date
- November 30, 2016
- Enrollment
- 129 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.